A basic study on usefulness of bleomycin adsorbed to Shirasu porous glass particles(SPG).
スポンサーリンク
概要
- 論文の詳細を見る
Shirasu porous glass particles (SPG) having a lot of pores of 500Å in diameter were prepared as a new drug carrier for cancer chemotherapy, and their chemical and biological features were studied. The particles are composed of SiO<SUB>2</SUB>, Al<SUB>2</SUB>O<SUB>3</SUB> and Bl<SUB>2</SUB>O<SUB>3</SUB>, and their mean diameter is 10<I>μ</I>m. Bleomycin(BLM) was used as an anti-cancer agent. SPG and BLM were shaken in saline of thermoincubator for 1 hour so that SPG could effectively adsorb BLM (SPG-BLM). About 40% of BLM was adsorbed to SPG at 37°C. On the other hand, the desorption of BLM from SPG-BLM was occurred in keeping the sigmoid relationship with the degree of dilution. The desorption rate was 82%, when SPG-BLM was diluted 8 times in saline. While ELM was immediately solved in saline, only about 30% of BLM was released into saline from SPG-BLM through the dialytic membrane at room temperature during 14 days. The biological activity of BLM was measured by thin agar plate bioassay using Bacillus subtilis PCL-219. The higher the concentration of SPG-BLM, the more significant the activity of BLM. And the activity became marked with the passage of time. In an acute toxicity experiment, no remarkable side-effects were observed both pharmacologically and histopathologically. Consequently, it was suggested that SPG are useful as a drug carrier and that administration of SPG-BLM is an effective anti-cancer modality especially in local chemotherapy.
- 日本DDS学会の論文
日本DDS学会 | 論文
- 固形腫瘍における分子標的薬の現状と課題 : 腎がんの経験から
- 前立腺がんにおけるホルモン療法
- ホルモン製剤のDDSの基礎と臨床 : 特集によせて
- SN-38内包高分子ミセルNK012日米独立 phase I 試験
- 多機能性エンベロープ型ナノ構造体による人工遺伝子デリバリーシステムの創製 : 第7回日本DDS学会永井賞受賞によせて